Shuttle Pharmaceuticals Holdings (SHPH) Other Operating Expenses (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $789026.0 for Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 1.1% year-over-year to $789026.0 in Q1 2026; TTM through Mar 2026 was $2.9 million, a 3.14% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 18.46% from the prior year.
• Other Operating Expenses retreated to $789026.0 in Q1 2026 per SHPH's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1.3 million in Q3 2024 and bottomed at $162769.0 in Q4 2022.
• The 5-year median for Other Operating Expenses is $416688.0 (2023), against an average of $517705.4.
• Biggest YoY gain for Other Operating Expenses was 574.42% in 2022; the steepest drop was 69.28% in 2022.
• Year by year, Other Operating Expenses stood at $162769.0 in 2022, then jumped by 67.6% to $272800.0 in 2023, then rose by 20.7% to $329265.0 in 2024, then jumped by 234.58% to $1.1 million in 2025, then slipped by 28.38% to $789026.0 in 2026.
• Per Business Quant, the three latest SHPH Other Operating Expenses figures stand at $789026.0 (Q1 2026), $1.1 million (Q4 2025), and $480887.0 (Q3 2025).